Earlier in February, the Russian Health Ministry said that the Russian-made drug Triazavirin had been sent to China at Beijing’s request for testing to assess its effectiveness as a treatment for those infected by the coronavirus.
Chinese scientists confirmed that a Russian-made drug, Triazavirin, according to preliminary research, is effective in treating COVID-19, Russian Science Academy Vice President Valery Charushin said.
According to Charushin, China has approved a clinical trial protocol, which envisages ten hospitals in the Heilongjiang province conducting randomized double-blind studies. Studies are conducted in patients with a mild to moderate severity of the illness.
The medicine was sent to China in February, at Beijing’s request, for testing as a potential coronavirus treatment, the Russian Health Ministry said.
According to the Medsintez plant, one of the developers, the drug targets the causes of illness but does not influence the immune system.
Triazavirin testing is ongoing in several hospitals in Yekaterinburg as well.
Russia created the world’s first vaccine against the coronavirus, dubbed Sputnik V. Developed by the Gamaleya Center and produced jointly with the Russian Direct Investment Fund (RDIF), the vaccine was registered on 11 August. Over 20 nations have expressed interest in its purchase.
Sourse: sputniknews.com
